The carbapenem antibiotics (imipenem, meropenem and doripenem) are considered the agents of choice for A. baumannii infections. The presence of resistance to these agents constrains therapeutic ...

Researchers discovered the ST164 variant of Carbapenem-resistant Acinetobacter baumannii (CRAB) in a Chinese intensive care unit (ICU) as part of their study into how bundled infection prevention ...

The pathogens labelled as critical are: • Acinetobacter baumannii, carbapenem-resistant. • Pseudomonas aeruginosa, carbapenem-resistant. Bacteria listed as critical are all Gram-negative.

Researchers discovered the ST164 variant of Carbapenem-resistant Acinetobacter baumannii (CRAB) in a Chinese intensive care unit (ICU) as part of their study into how bundled infection prevention and ...

Researchers discovered the ST164 variant of Carbapenem-resistant Acinetobacter baumannii (CRAB) in a Chinese intensive care unit (ICU) as part of their study into how bundled infection prevention ...

Zai Lab (“Zai Lab”, NASDAQ: ZLAB; HKEX: 9688) and Pfizer (“Pfizer”, NYSE: PFE) announced today a strategic collaboration for ...

The first study evaluated the in vitro antimicrobial activity of eravacycline against Carbapenem-resistant Acinetobacter baumannii (CRAB), using broth microdilution, MIC test strip (MTS), and disk ...